HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brain metabolism modulates neuronal excitability in a mouse model of pyruvate dehydrogenase deficiency.

Abstract
Glucose is the ultimate substrate for most brain activities that use carbon, including synthesis of the neurotransmitters glutamate and γ-aminobutyric acid via mitochondrial tricarboxylic acid (TCA) cycle. Brain metabolism and neuronal excitability are thus interdependent. However, the principles that govern their relationship are not always intuitive because heritable defects of brain glucose metabolism are associated with the paradoxical coexistence, in the same individual, of episodic neuronal hyperexcitation (seizures) with reduced basal cerebral electrical activity. One such prototypic disorder is pyruvate dehydrogenase (PDH) deficiency (PDHD). PDH is central to metabolism because it steers most of the glucose-derived flux into the TCA cycle. To better understand the pathophysiology of PDHD, we generated mice with brain-specific reduced PDH activity that paralleled salient human disease features, including cerebral hypotrophy, decreased amplitude electroencephalogram (EEG), and epilepsy. The mice exhibited reductions in cerebral TCA cycle flux, glutamate content, spontaneous, and electrically evoked in vivo cortical field potentials and gamma EEG oscillation amplitude. Episodic decreases in gamma oscillations preceded most epileptiform discharges, facilitating their prediction. Fast-spiking neuron excitability was decreased in brain slices, contributing to in vivo action potential burst prolongation after whisker pad stimulation. These features were partially reversed after systemic administration of acetate, which augmented cerebral TCA cycle flux, glutamate-dependent synaptic transmission, inhibition and gamma oscillations, and reduced epileptiform discharge duration. Thus, our results suggest that dysfunctional excitability in PDHD is consequent to reduced oxidative flux, which leads to decreased neuronal activation and impaired inhibition, and can be mitigated by an alternative metabolic substrate.
AuthorsVikram Jakkamsetti, Isaac Marin-Valencia, Qian Ma, Levi B Good, Tyler Terrill, Karthik Rajasekaran, Kumar Pichumani, Chalermchai Khemtong, M Ali Hooshyar, Chandrasekhar Sundarrajan, Mulchand S Patel, Robert M Bachoo, Craig R Malloy, Juan M Pascual
JournalScience translational medicine (Sci Transl Med) Vol. 11 Issue 480 (02 20 2019) ISSN: 1946-6242 [Electronic] United States
PMID30787166 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Chemical References
  • Acetates
  • Carbon Isotopes
  • Glutamic Acid
  • Carbon-13
  • Glucose
Topics
  • Acetates (metabolism)
  • Algorithms
  • Animals
  • Brain (metabolism)
  • Carbon Isotopes
  • Cerebral Cortex (metabolism)
  • Disease Models, Animal
  • Electroencephalography
  • Evoked Potentials
  • Gamma Rhythm
  • Glucose (metabolism)
  • Glutamic Acid (metabolism)
  • Humans
  • Machine Learning
  • Mice
  • Neural Inhibition
  • Neurons (physiology)
  • Pyruvate Dehydrogenase Complex Deficiency Disease (metabolism, physiopathology)
  • Seizures (metabolism, physiopathology)
  • Vibrissae

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: